Suresh K. Durgam - 02 Mar 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Chief Medical Officer
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
02 Mar 2022
Net transactions value
-$452,313
Form type
4
Filing time
04 Mar 2022, 17:05:25 UTC
Previous filing
25 Feb 2022
Next filing
14 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Sale $238,005 -4,177 -13% $56.98 26,964 02 Mar 2022 Direct F1
transaction ITCI Common Stock Sale $214,307 -3,860 -14% $55.52 23,104 04 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2021.